These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9763109

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Correlation of c-kit expression and cell cycle regulation by transforming growth factor-beta in CD34+ CD38- human bone marrow cells.
    Morita N, Yamamoto M, Tanizawa T.
    Eur J Haematol; 2003 Nov; 71(5):351-8. PubMed ID: 14667198
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cells.
    Willems R, Henckaerts E, Lenjou M, Nijs G, Rodrigus I, Moulijn AC, Slegers H, Berneman ZN, Van Bockstaele DR.
    Ann Hematol; 2001 Jan; 80(1):17-25. PubMed ID: 11233770
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transforming growth factor-beta(1) induces apoptosis in CD34(+)CD38(-/low) cells that express Bcl-2 at a low level.
    Xiao M, Oppenlander BK, Dooley DC.
    Exp Hematol; 2001 Sep; 29(9):1098-108. PubMed ID: 11532351
    [Abstract] [Full Text] [Related]

  • 29. Broad distribution of colony-forming cells with erythroid, myeloid, dendritic cell, and NK cell potential among CD34(++) fetal liver cells.
    Muench MO, Bárcena A.
    J Immunol; 2001 Nov 01; 167(9):4902-9. PubMed ID: 11673495
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
    Harvey K, Higgins N, Akard L, Chang Q, Jansen J, Thompson J, Dugan M, Rizzo MT, English D.
    J Hematother; 1997 Jun 01; 6(3):243-52. PubMed ID: 9234179
    [Abstract] [Full Text] [Related]

  • 33. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G, Malangone W, Adami V, Risso A, Dorotea L, Falasca E, Marini L, Spizzo R, Bigi L, Sala P, Tonutti E, Biffoni F, Rinaldi C, Del Frate G, Pittino M, Degrassi A.
    Blood Cells Mol Dis; 2001 Jun 01; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [Abstract] [Full Text] [Related]

  • 34. Biology of CD34+CD38- cells in lymphohematopoiesis.
    Novelli EM, Ramirez M, Civin CI.
    Leuk Lymphoma; 1998 Oct 01; 31(3-4):285-93. PubMed ID: 9869192
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression.
    Sakabe H, Yahata N, Kimura T, Zeng ZZ, Minamiguchi H, Kaneko H, Mori KJ, Ohyashiki K, Ohyashiki JH, Toyama K, Abe T, Sonoda Y.
    Leukemia; 1998 May 01; 12(5):728-34. PubMed ID: 9593271
    [Abstract] [Full Text] [Related]

  • 37. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G, Bartke I, Kempkes B, Kostka G, Ellwart J, Birner A, Thalmeier K, Mailhammer R, Bornkamm GW, Ullrich A.
    Exp Hematol; 1993 Jan 01; 21(1):74-9. PubMed ID: 7678090
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Expression of CD43 on murine and human pluripotent hematopoietic stem cells.
    Moore T, Huang S, Terstappen LW, Bennett M, Kumar V.
    J Immunol; 1994 Dec 01; 153(11):4978-87. PubMed ID: 7525720
    [Abstract] [Full Text] [Related]

  • 40. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
    Ohkubo T, Bárcena A, Smith CA, Harrison MR, Muench MO.
    Fetal Diagn Ther; 2001 Dec 01; 16(5):299-307. PubMed ID: 11509853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.